Current IACM-Bulletins
The IACM-Bulletin is a FREE bi-weekly e-mail newsletter, covering news topics on all aspects of Cannabis as medicine. To receive IACM-Bulletin per e-mail, please subscribe online.
[IACM Homepage] [IACM-Bulletin Year 2023] [2022] [2021] [2020] [2019] [2018] [2017] [2015] [2014] [2013] [2012] [2011] [2010] [2009] [2008] [2007] [2006] [2005] [2004] [2003] [2002] [2001] [2000]
- IACM-Bulletin of 27 November 2016
- Science/Human: Cannabis use improved cognitive function in a longitudinal study
- Holland: Ruling party supports legalization of cannabis cultivation
- Science/Human: Cannabis and CBD may be helpful in reducing the hard drugs
- Science/Human: Cannabis extracts significantly improved epilepsy in about a quarter of patients
- IACM-Bulletin of 16 October 2016
- Science/Human: In states of the USA with medical cannabis laws there is a greater workforce participation and an improvement in overall health of older individuals
- Science/Human: Cannabis improves pain and movement in patients with Parkinson’s disease in open clinical study
- Science/Human: Cannabidiol may be effective in the treatment of epilepsy due to tuberous sclerosis
- IACM-Bulletin of 02 October 2016
- Germany: First patient gets a permission to grow his own cannabis
- Science/Human: Cannabidiol is effective in febrile infection-related epilepsy syndrome in a case series
- Science/Human: Cannabidiol improves severe form of childhood epilepsy in controlled clinical trial
- Science/Human: The synthetic cannabinoid Resunab reduces inflammation in healthy subjects
- IACM-Bulletin of 17 April 2016
- Australia: Victoria has become the first state to legalise the medicinal use of cannabis
- Germany: Federal Administrative Court forces the Federal Health Ministry to allow cultivation of cannabis for personal medicinal use
- USA: Pennsylvania will legalise the medical use of cannabis
- Science/Human: Cannabis use was associated with a reduced early death after heart attack
- IACM-Bulletin of 03 April 2016
- Science/Human: Cannabis reduces the stretch reflex in patients with multiple sclerosis
- Canada: The right to grow cannabis for their own remains legal for patients
- Brazil: Government allows prescription and importation of products with CBD and THC
- USA: War veterans are increasingly using cannabis to treat post-traumatic stress disorder
- IACM-Bulletin of 06 March 2016
- IACM: Partner organizations selected and educational cooperation with ICEERS
- Australia: Parliament legalizes the medical use of cannabis
- Canada: Patients may continue to grow their own cannabis, a federal court rules
- Science/Human: Good long-terms effects of the cannabis spray Sativex in several studies
- IACM-Bulletin of 24 January 2016
- Science/Human: Patients with migraine may profit from cannabis according to an observational study
- Science/Human: Cannabis oil may help in the treatment of symptoms of Alzheimer’s disease
- Science/Human: Cannabis reduced neuropathic pain in patients with multiple sclerosis in an open study
- Science/France: FAAH inhibitor caused death of a man in a phase I trial
- IACM-Bulletin of 09 January 2016
- Germany: The government presents a draft for a law, which would make cannabis flowers available on prescription by every doctor and force health insurances to reimburse cannabis-based medicines in certain cases
- Science/Human: Cannabidiol reduces seizure frequency in epilepsy of children and young adults according to open clinical study
- Science/Human: Pre-treatment with CBD did not influence effects of smoked cannabis
Online Events 2020
Please find all information of IACM Online Events including free videos of the webinars here.
Conference 2022
The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.